11
Views
6
CrossRef citations to date
0
Altmetric
REGULAR ARTICLES

The Inclusion of Women and Minorities in Smoking Cessation Clinical Trials: A Systematic Review

, DO, MPH, , PhD, , PhD & , PhD
Pages 21-28 | Received 26 Feb 2008, Accepted 24 Apr 2008, Published online: 10 Jul 2009

REFERENCES

  • Fagan P, Moolchan E T, Lawrence D, Fernander A, Ponder P K. Identifying health disparities across the tobacco continuum. Addiction. 2007; 102: 5–29
  • Shopland D R, Burns D M, Garfinkel L, et al. Monograph 8: Changes in Cigarette Related Disease Risks and Their Implications for Prevention and Control. National Institutes of Health, National Cancer Institute, Bethesda, Md 1997, NIH Publication Number 97-4213
  • Centers for Disease Control and Prevention. Cigarette smoking among adults—United States, 2006. MMWR Morb Mortal Wkly Rep 2007; 56: 1157–1161
  • Grant B F, Hasin D S, Chou S P, Stinson F S, Dawson D A. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry. 2004; 61: 1107–1115
  • American Lung Association. Trends in tobacco use. 2006, Available at: http://www.lungusa.org/atf/cf/%7B7A8D42C2-FCCA-4604-8ADE-7F5D5E762256%7D/Smoking2006.pdf Accessed May 21, 2007
  • National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. March 18, 1994, Available at: http://grants.nih.gov/grants/guide/notice-files/not94-100.html Accessed January 15, 2008
  • National Institutes of Health Tracking/Inclusion Committee. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research. September, 2000, Available at: http://orwh.od.nih.gov/inclusion/fy97-98trkg.pdf Comprehensive report, fiscal year 1997 and 1998 tracking data. Accessed November 26, 2007
  • United States Food and Drug Administration. November 21, 1997, Available at: http://www.fda.gov/cdrh/modact97.pdf FDA Modernization Act of 1997. Accessed January 15, 2008
  • Evelyn B, Toigo T, Banks D, et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: A review of new molecular entities approved 1995–1999. J Natl Med Assoc. 2001; 93: 18S–24S
  • Geller S E, Adams M B, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Womens Health. 2006; 15: 1123–1131
  • Ramasubbu K, Gurm H, Litaker D. Gender bias in clinical trials: Do double standards still apply?. J Womens Health Gend Based Med. 2001; 10: 757–764
  • Vidaver R M, LaFleur B, Tong C, Bradshaw R, Marts A. Women subjects in NIH-funded clinical research literature: Lack of progress in both representation and analysis by sex. J Womens Health Gend Based Med 2000; 9: 495–504
  • General Accounting Office. Women's health: NIH has increased its efforts to include women in research. May, 2000, Available at: http://www.gao.gov/new.items/he00096.pdf Accessed January 15, 2008
  • Murthy V H, Krumholz H M, Gross C P. Participation in cancer clinical trials. Race, sex-, and age-based disparities. JAMA 2004; 291: 2720–2726
  • Corbie-Smith G, St George D M, Moody-Ayers S, Ransohoff D F. Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities. J Clin Epidemiol. 2003; 56: 416–420
  • Guevara C, Cook C, Herback N, et al. Gender, racial and ethnic disclosure in NIH K Award funded diabetes and obesity clinical trials. Account Res 2006; 13: 311–324
  • Xu F, Yin X, Shen H, Xu Y, Ware R S, Owen N. Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: A case control study in mainland China. Respirology 2007; 12: 891–897
  • Howe H L, Wu X, Ries L A, et al. Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U. S. Hispanic/Latino populations. Cancer. 2006; 107: 1711–1742
  • Waldron I. Trends in gender differences in mortality: Relationships to changing gender differences in behaviour and other causal factors. Inequalities in Health, E Annandale, K Hunt. Open University Press, Buckingham 2000; 150–181
  • Perkins K A. Smoking cessation in women: Special considerations. CNS Drugs. 2001; 15: 391–411
  • Pletcher M J, Hulley B J, Houston T, Kiefe C I, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: The coronary artery risk development in young adults (CARDIA) study. Arch Intern Med. 2006; 166: 1915–1922
  • Wetter D W, Mazas C, Daza P, et al. Reaching and treating Spanish-speaking smokers through the National Cancer Institute's cancer information service. A randomized controlled trial. Cancer. 2007; 109(Suppl. 2)406–413
  • Centers for Disease Control and Prevention. Cigarette smoking among adults—United States, 2005. MMWR Morb Mortal Wkly Rep 2006; 54: 1145–1148
  • Leeman R F, Huffman C J, O'Malley S S. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: A review. Alcohol Alcohol. 2007; 42: 42–48
  • Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004, (3). No.: CD00146.pub2. DOI: 10.1002/14651858
  • Hughes J R, Stead L F, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 2004, (4). No.: CD000031. DOI: 10.1002/14651858
  • Cooper T V, Klesges R C, DeBon M W, Zbikowski S M, Johnson K C, Clemens L H. A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addict Behav. 2005; 30: 61–75
  • Pirie P L, McBride C M, Hellerstedt W, et al. Smoking cessation in women concerned about weight. Am J Public Health 1992; 82: 1238–1243
  • Ahluwalia J S, McNagny S E, Clark W S. Smoking cessation among inner-city African Americans using the nicotine patch. J Gen Intern Med. 1998; 13: 55–57
  • Ahluwalia J S, Harris K J, Catley D, Okuyemi K S, Mayo M S. Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. JAMA. 2002; 288: 468–474
  • Harrison R W. Impact of biomedical research on African Americans. J Natl Med Assoc. 2001; 93(Suppl. 3)6S–7S
  • Hussain-Gambles M, Atkin K, Leese B. Why ethnic minority groups are under-represented in clinical trials: A review of the literature. Health Soc Care Community. 2004; 12: 382–388
  • Fujimoto W Y. Community involvement and minority participation in clinical research. Diabetes Spectr. 1998; 11: 161–166
  • Office of Minority Health. Cancer data/statistics, Available at: http://www.omhrc.gov/templates/browse.aspx?lvl=2&lvlID=9 Accessed September 27, 2007
  • Sherer R. Surgeon general's report highlights mental health problems among minorities. Psychiatric Times. 2002; 19: 1–4
  • Baezconde-Garbanati L, Beebe L A, Perez-Stable E J. Building capacity to address tobacco-related disparities among American Indian and Hispanic/Latino communities: Conceptual and systemic considerations. Addiction. 2007; 102(Suppl. 2)112–122
  • Moolchan E T, Fagan P, Fernander A F, et al. Addressing tobacco-related health disparities. Addiction. 2007; 102(Suppl. 2)30–42
  • Wang M S, Lagakos S W, Ware J H, Hunter D, Drazen J M. Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med. 2007; 357: 2189–2194

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.